Afinitor 5 mg tablets, PLACEBO
UC-0140/1208
Phase 3 small_molecule active
Quick answer
Afinitor 5 mg tablets, PLACEBO for Patients with high risk of relapse, ER+ and HER2- primary non-metastatic breast cancer who remain disease-free is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Patients with high risk of relapse, ER+ and HER2- primary non-metastatic breast cancer who remain disease-free
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active